Syndax PharmaceuticalsSNDX
那斯達克 · USD
24.07
-0.38
(-1.53%)
盤中 03/13 01:35 (UTC+8)
03/13 01:35 (UTC+8)
Syndax PharmaceuticalsSNDX
24.07
-0.38
(-1.53%)
財務數據
損益表
- -
- -
- -
- 0.04
- 0.13
- 0.08
- 0.20
- 0.38
- 0.46
- 0.69
- -
- -
- -
- -
- 257.14
- -38.56
- 160.96
- 88.16
- 21.64
- 49.83
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 68,728 | 45,871 | 37,711 | 20,042 | 7,680 | 12,500 | 3,500 | - | - | - |
營業成本 | 2,706 | 2,100 | 1,279 | 885 | 826 | - | - | - | - | - |
營業毛利 | 66,022 | 43,771 | 36,432 | 19,157 | 6,854 | 12,500 | 3,500 | - | - | - |
營業費用 | 128,570 | 101,197 | 105,785 | 102,914 | 103,219 | 102,077 | - | - | 77,905 | 56,355 |
研發費用 | 78,641 | 56,280 | 62,227 | 61,636 | 65,529 | 70,971 | 48,655 | 56,492 | 55,126 | 39,087 |
推銷及管理費用 | 49,929 | 44,917 | 43,558 | 41,278 | 37,690 | 31,106 | 29,061 | 23,022 | 22,779 | 17,268 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -62,548 | -57,426 | -69,353 | -83,757 | -96,365 | -89,577 | -74,216 | -79,514 | -77,905 | -56,355 |
其他收入及費用 | 4,121 | 4,994 | 5,364 | 6,962 | 7,002 | 5,474 | 6,198 | 7,169 | 5,495 | 5,279 |
利息費用 | 9,587 | 8,283 | 7,858 | 8,051 | 4,806 | 23 | 45 | 55 | 63 | 70 |
稅前純益 | -68,014 | -60,715 | -71,847 | -84,846 | -94,169 | -84,126 | -68,063 | -72,400 | -72,473 | -51,146 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -68,014 | -60,715 | -71,847 | -84,846 | -94,169 | -84,126 | -68,063 | -72,400 | -72,473 | -51,146 |
基本每股稅後盈餘(元) | -0.78 | -0.70 | -0.83 | -0.98 | -1.10 | -0.98 | -0.80 | -0.85 | -1.00 | -0.73 |
稀釋每股稅後盈餘(元) | -0.78 | -0.70 | -0.83 | -0.98 | -1.09 | -0.98 | -0.80 | -0.85 | -1.01 | -0.74 |
基本平均股數(千股) | 87359.00 | 86620.00 | 86337.00 | 86171.00 | 85791.00 | 85433.00 | 85274.00 | 85213.00 | 72520.00 | 69855.00 |
稀釋平均股數(千股) | 87359.00 | 86620.00 | 86337.00 | 86171.00 | 85791.00 | 85433.00 | 85274.00 | 85213.00 | 72520.00 | 69855.00 |
還原基本每股稅後盈餘(元) | -0.78 | -0.70 | -0.83 | -0.98 | -1.10 | -0.98 | -0.80 | -0.85 | -1.00 | -0.73 |
還原稀釋每股稅後盈餘(元) | -0.78 | -0.70 | -0.83 | -0.98 | -1.09 | -0.98 | -0.80 | -0.85 | -1.01 | -0.74 |
還原基本平均股數(千股) | 87,359 | 86,620 | 86,337 | 86,171 | 85,791 | 85,433 | 85,274 | 85,213 | 72,520 | 69,855 |
還原稀釋平均股數(千股) | 87,359 | 86,620 | 86,337 | 86,171 | 85,791 | 85,433 | 85,274 | 85,213 | 72,520 | 69,855 |
EBITDA(千元) | -59,955 | -54,780 | -67,145 | -80,282 | -92,273 | -87,159 | -71,664 | -76,163 | -75,866 | -54,732 |